Pre-order Enquiry
Request Free Sample
Global Urological Cancer Therapeutics Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
SKU ID : GIR-15448928 | Publishing Date : 16-Mar-2020 | No. of pages : 132
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Urological Cancer Therapeutics Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Table of Contents1 Market Overview
1.1 Urological Cancer Therapeutics Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Urological Cancer Therapeutics Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Xofigo (radium Ra 223 dichloride)
1.2.3 Jevtana (cabazitaxel)
1.2.4 Inlyta (axitinib)
1.2.5 Votrient (pazopanib hydrochloride)
1.2.6 Sutent (sunitinib malate)
1.2.7 Zytiga (abiraterone acetate)
1.2.8 Xtandi (enzalutamide)
1.2.9 Opdivo (nivolumab)
1.2.10 Provenge (sipuleucel-T)
1.3 Market Analysis by Application
1.3.1 Overview: Global Urological Cancer Therapeutics Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Overview of Global Urological Cancer Therapeutics Drugs Market
1.4.1 Global Urological Cancer Therapeutics Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celgene Corporation
2.2.1 Celgene Corporation Details
2.2.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Celgene Corporation SWOT Analysis
2.2.4 Celgene Corporation Product and Services
2.2.5 Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca SWOT Analysis
2.3.4 AstraZeneca Product and Services
2.3.5 AstraZeneca Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Abbott Laboratories
2.5.1 Abbott Laboratories Details
2.5.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Abbott Laboratories SWOT Analysis
2.5.4 Abbott Laboratories Product and Services
2.5.5 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ferring Pharmaceuticals
2.7.1 Ferring Pharmaceuticals Details
2.7.2 Ferring Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ferring Pharmaceuticals SWOT Analysis
2.7.4 Ferring Pharmaceuticals Product and Services
2.7.5 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bristol-Myers Squibb SWOT Analysis
2.8.4 Bristol-Myers Squibb Product and Services
2.8.5 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Astellas
2.9.1 Astellas Details
2.9.2 Astellas Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Astellas SWOT Analysis
2.9.4 Astellas Product and Services
2.9.5 Astellas Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Dendreon Corporation
2.10.1 Dendreon Corporation Details
2.10.2 Dendreon Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Dendreon Corporation SWOT Analysis
2.10.4 Dendreon Corporation Product and Services
2.10.5 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sanofi S.A.
2.11.1 Sanofi S.A. Details
2.11.2 Sanofi S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sanofi S.A. SWOT Analysis
2.11.4 Sanofi S.A. Product and Services
2.11.5 Sanofi S.A. Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 GlaxoSmithKline plc
2.12.1 GlaxoSmithKline plc Details
2.12.2 GlaxoSmithKline plc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 GlaxoSmithKline plc SWOT Analysis
2.12.4 GlaxoSmithKline plc Product and Services
2.12.5 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Roche Healthcare
2.13.1 Roche Healthcare Details
2.13.2 Roche Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Roche Healthcare SWOT Analysis
2.13.4 Roche Healthcare Product and Services
2.13.5 Roche Healthcare Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Indevus Pharmaceuticals Inc
2.14.1 Indevus Pharmaceuticals Inc Details
2.14.2 Indevus Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Indevus Pharmaceuticals Inc SWOT Analysis
2.14.4 Indevus Pharmaceuticals Inc Product and Services
2.14.5 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Ipsen
2.15.1 Ipsen Details
2.15.2 Ipsen Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Ipsen SWOT Analysis
2.15.4 Ipsen Product and Services
2.15.5 Ipsen Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Urological Cancer Therapeutics Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Urological Cancer Therapeutics Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Urological Cancer Therapeutics Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Urological Cancer Therapeutics Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Urological Cancer Therapeutics Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Urological Cancer Therapeutics Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Urological Cancer Therapeutics Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.5 South America Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Urological Cancer Therapeutics Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Urological Cancer Therapeutics Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Urological Cancer Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Urological Cancer Therapeutics Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Urological Cancer Therapeutics Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Urological Cancer Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.3 UK Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.4 France Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Urological Cancer Therapeutics Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.5 India Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Urological Cancer Therapeutics Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Urological Cancer Therapeutics Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Urological Cancer Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Urological Cancer Therapeutics Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Urological Cancer Therapeutics Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Urological Cancer Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Urological Cancer Therapeutics Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Urological Cancer Therapeutics Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Urological Cancer Therapeutics Drugs Price by Type (2015-2020)
11 Global Urological Cancer Therapeutics Drugs Market Segment by Application
11.1 Global Urological Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
11.2 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Urological Cancer Therapeutics Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Urological Cancer Therapeutics Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Urological Cancer Therapeutics Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Urological Cancer Therapeutics Drugs Market Forecast (2021-2025)
12.2.2 Europe Urological Cancer Therapeutics Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Urological Cancer Therapeutics Drugs Market Forecast (2021-2025)
12.2.4 South America Urological Cancer Therapeutics Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Urological Cancer Therapeutics Drugs Market Forecast (2021-2025)
12.3 Urological Cancer Therapeutics Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Urological Cancer Therapeutics Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Urological Cancer Therapeutics Drugs Market Share Forecast by Type (2021-2025)
12.4 Urological Cancer Therapeutics Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Urological Cancer Therapeutics Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Urological Cancer Therapeutics Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
List of Figures, Tables and Charts Available in Global Urological Cancer Therapeutics Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
List of TablesTable 1. Global Urological Cancer Therapeutics Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Urological Cancer Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Urological Cancer Therapeutics Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Urological Cancer Therapeutics Drugs Major Business
Table 9. Novartis Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 10. Novartis SWOT Analysis
Table 11. Novartis Urological Cancer Therapeutics Drugs Product and Services
Table 12. Novartis Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 14. Celgene Corporation Urological Cancer Therapeutics Drugs Major Business
Table 15. Celgene Corporation Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 16. Celgene Corporation SWOT Analysis
Table 17. Celgene Corporation Urological Cancer Therapeutics Drugs Product and Services
Table 18. Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Urological Cancer Therapeutics Drugs Major Business
Table 21. AstraZeneca Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 22. AstraZeneca SWOT Analysis
Table 23. AstraZeneca Urological Cancer Therapeutics Drugs Product and Services
Table 24. AstraZeneca Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Urological Cancer Therapeutics Drugs Major Business
Table 27. Pfizer Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Urological Cancer Therapeutics Drugs Product and Services
Table 30. Pfizer Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 32. Abbott Laboratories Urological Cancer Therapeutics Drugs Major Business
Table 33. Abbott Laboratories Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 34. Abbott Laboratories SWOT Analysis
Table 35. Abbott Laboratories Urological Cancer Therapeutics Drugs Product and Services
Table 36. Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 38. Johnson & Johnson Urological Cancer Therapeutics Drugs Major Business
Table 39. Johnson & Johnson Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 40. Johnson & Johnson SWOT Analysis
Table 41. Johnson & Johnson Urological Cancer Therapeutics Drugs Product and Services
Table 42. Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Major Business
Table 45. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 46. Ferring Pharmaceuticals SWOT Analysis
Table 47. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Product and Services
Table 48. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 50. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Major Business
Table 51. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 52. Bristol-Myers Squibb SWOT Analysis
Table 53. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Product and Services
Table 54. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Astellas Basic Information, Manufacturing Base and Competitors
Table 56. Astellas Urological Cancer Therapeutics Drugs Major Business
Table 57. Astellas Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 58. Astellas SWOT Analysis
Table 59. Astellas Urological Cancer Therapeutics Drugs Product and Services
Table 60. Astellas Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Dendreon Corporation Basic Information, Manufacturing Base and Competitors
Table 62. Dendreon Corporation Urological Cancer Therapeutics Drugs Major Business
Table 63. Dendreon Corporation Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 64. Dendreon Corporation SWOT Analysis
Table 65. Dendreon Corporation Urological Cancer Therapeutics Drugs Product and Services
Table 66. Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi S.A. Urological Cancer Therapeutics Drugs Major Business
Table 69. Sanofi S.A. Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 70. Sanofi S.A. SWOT Analysis
Table 71. Sanofi S.A. Urological Cancer Therapeutics Drugs Product and Services
Table 72. Sanofi S.A. Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 74. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Major Business
Table 75. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 76. GlaxoSmithKline plc SWOT Analysis
Table 77. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Product and Services
Table 78. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Roche Healthcare Basic Information, Manufacturing Base and Competitors
Table 80. Roche Healthcare Urological Cancer Therapeutics Drugs Major Business
Table 81. Roche Healthcare Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 82. Roche Healthcare SWOT Analysis
Table 83. Roche Healthcare Urological Cancer Therapeutics Drugs Product and Services
Table 84. Roche Healthcare Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Indevus Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 86. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Major Business
Table 87. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 88. Indevus Pharmaceuticals Inc SWOT Analysis
Table 89. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Product and Services
Table 90. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Ipsen Basic Information, Manufacturing Base and Competitors
Table 92. Ipsen Urological Cancer Therapeutics Drugs Major Business
Table 93. Ipsen Urological Cancer Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 94. Ipsen SWOT Analysis
Table 95. Ipsen Urological Cancer Therapeutics Drugs Product and Services
Table 96. Ipsen Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Urological Cancer Therapeutics Drugs Sales by Manufacturer (2018-2019) (K MT)
Table 98. Global Urological Cancer Therapeutics Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Urological Cancer Therapeutics Drugs Sales by Regions (2015-2020) (K MT)
Table 100. Global Urological Cancer Therapeutics Drugs Sales Market Share by Regions (2015-2020)
Table 101. Global Urological Cancer Therapeutics Drugs Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Urological Cancer Therapeutics Drugs Sales by Countries (2015-2020) (K MT)
Table 103. North America Urological Cancer Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 104. North America Urological Cancer Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Urological Cancer Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 106. Europe Urological Cancer Therapeutics Drugs Sales by Countries (2015-2020) (K MT)
Table 107. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 108. Europe Urological Cancer Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Urological Cancer Therapeutics Drugs Sales by Regions (2015-2020) (K MT)
Table 110. Asia-Pacific Urological Cancer Therapeutics Drugs Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Urological Cancer Therapeutics Drugs Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Urological Cancer Therapeutics Drugs Sales by Countries (2015-2020) (K MT)
Table 113. South America Urological Cancer Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 114. South America Urological Cancer Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Urological Cancer Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Urological Cancer Therapeutics Drugs Sales by Countries (2015-2020) (K MT)
Table 117. Middle East & Africa Urological Cancer Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Urological Cancer Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Urological Cancer Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 120. Global Urological Cancer Therapeutics Drugs Sales by Type (2015-2020) (K MT)
Table 121. Global Urological Cancer Therapeutics Drugs Sales Share by Type (2015-2020)
Table 122. Global Urological Cancer Therapeutics Drugs Revenue by Type (2015-2020) (USD Million)
Table 123. Global Urological Cancer Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 124. Global Urological Cancer Therapeutics Drugs Sales by Application (2015-2020) (K MT)
Table 125. Global Urological Cancer Therapeutics Drugs Sales Share by Application (2015-2020)
Table 126. Global Urological Cancer Therapeutics Drugs Sales Forecast by Regions (2021-2025) (K MT)
Table 127. Global Urological Cancer Therapeutics Drugs Market Share Forecast by Regions (2021-2025)
Table 128. Global Urological Cancer Therapeutics Drugs Sales Forecast by Type (2021-2025) (K MT)
Table 129. Global Urological Cancer Therapeutics Drugs Market Share Forecast by Type (2021-2025)
Table 130. Global Urological Cancer Therapeutics Drugs Sales Forecast by Application (2021-2025)
Table 131. Global Urological Cancer Therapeutics Drugs Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Urological Cancer Therapeutics Drugs Picture
Figure 2. Global Sales Market Share of Urological Cancer Therapeutics Drugs by Type in 2019
Figure 3. Xofigo (radium Ra 223 dichloride) Picture
Figure 4. Jevtana (cabazitaxel) Picture
Figure 5. Inlyta (axitinib) Picture
Figure 6. Votrient (pazopanib hydrochloride) Picture
Figure 7. Sutent (sunitinib malate) Picture
Figure 8. Zytiga (abiraterone acetate) Picture
Figure 9. Xtandi (enzalutamide) Picture
Figure 10. Opdivo (nivolumab) Picture
Figure 11. Provenge (sipuleucel-T) Picture
Figure 12. Urological Cancer Therapeutics Drugs Sales Market Share by Application in 2018
Figure 13. Hospital Picture
Figure 14. Medical Research Laboratory Picture
Figure 15. Others Picture
Figure 16. Global Urological Cancer Therapeutics Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Urological Cancer Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Urological Cancer Therapeutics Drugs Sales Market Share by Manufacturer in 2019
Figure 37. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Urological Cancer Therapeutics Drugs Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Urological Cancer Therapeutics Drugs Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 42. Global Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Regions (2015-2020)
Figure 44. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Regions in 2018
Figure 45. North America Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 46. Europe Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 48. South America Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 50. North America Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Urological Cancer Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Figure 52. North America Urological Cancer Therapeutics Drugs Sales Market Share by Countries in 2018
Figure 53. North America Urological Cancer Therapeutics Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Urological Cancer Therapeutics Drugs Revenue Market Share by Countries in 2018
Figure 55. United States Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 56. Canada Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Mexico Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Europe Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Urological Cancer Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Urological Cancer Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 61. Germany Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 62. UK Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 63. France Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Russia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Italy Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Asia-Pacific Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Urological Cancer Therapeutics Drugs Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Urological Cancer Therapeutics Drugs Revenue Market Share by Regions 2019
Figure 69. China Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Japan Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Korea Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 72. India Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Southeast Asia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 74. South America Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Urological Cancer Therapeutics Drugs Sales Market Share by Countries in 2019
Figure 76. South America Urological Cancer Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 77. Brazil Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Argentina Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Urological Cancer Therapeutics Drugs Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 84. Egypt Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 85. Turkey Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 86. South Africa Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 87. Global Urological Cancer Therapeutics Drugs Sales and Growth Rate (2021-2025) (K MT)
Figure 88. Global Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Urological Cancer Therapeutics Drugs Market Forecast (2021-2025) (K MT)
Figure 90. Europe Sales Urological Cancer Therapeutics Drugs Market Forecast (2021-2025) (K MT)
Figure 91. Asia-Pacific Sales Urological Cancer Therapeutics Drugs Market Forecast (2021-2025) (K MT)
Figure 92. South America Sales Urological Cancer Therapeutics Drugs Market Forecast (2021-2025) (K MT)
Figure 93. Middle East & Africa Sales Urological Cancer Therapeutics Drugs Market Forecast (2021-2025) (K MT)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
Keyplayers in Global Urological Cancer Therapeutics Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
NovartisCelgene Corporation
AstraZeneca
Pfizer
Abbott Laboratories
Johnson & Johnson
Ferring Pharmaceuticals
Bristol-Myers Squibb
Astellas
Dendreon Corporation
Sanofi S.A.
GlaxoSmithKline plc
Roche Healthcare
Indevus Pharmaceuticals Inc
Ipsen
